| MeSH term | MeSH ID | Detail |
|---|---|---|
| Dyslipidemias | D050171 | 7 associated lipids |
| Hashimoto Disease | D050031 | 1 associated lipids |
| Hyperparathyroidism, Primary | D049950 | 1 associated lipids |
| Diabetes Complications | D048909 | 4 associated lipids |
| Hypertension, Pregnancy-Induced | D046110 | 2 associated lipids |
| Scleroderma, Limited | D045745 | 1 associated lipids |
| Glucose Metabolism Disorders | D044882 | 3 associated lipids |
| Malnutrition | D044342 | 6 associated lipids |
| Irritable Bowel Syndrome | D043183 | 8 associated lipids |
| Mastocytoma | D034801 | 3 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Brändström H et al. | Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9642127 |
| Tsukii K et al. | Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9610359 |
| Emery JG et al. | Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. | 1998 | J. Biol. Chem. | pmid:9603945 |
| Matsuzaki K et al. | Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9600092 |
| Bucay N et al. | osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. | 1998 | Genes Dev. | pmid:9573043 |
| Tomoyasu A et al. | Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9571159 |
| Lacey DL et al. | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. | 1998 | Cell | pmid:9568710 |
| Yasuda H et al. | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. | 1998 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9520411 |
| Yasuda H et al. | Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. | 1998 | Endocrinology | pmid:9492069 |
| Yamaguchi K et al. | Characterization of structural domains of human osteoclastogenesis inhibitory factor. | 1998 | J. Biol. Chem. | pmid:9478964 |